| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.57 | 0.0002 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.55 | 0.0006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.2 | 0.0009 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.007 |